WHO ICTRP trial

Using lab-grown mini-tumors from pancreatic cancer tissue to predict and improve…

CTIS2023-510490-34-00 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2023-510490-34-00
Public title Using lab-grown mini-tumors from pancreatic cancer tissue to predict and improve post-surgery treatment for pancreatic cancer
Scientific title Using organoids to predict efficacy of adjuvant treatment to improve outcome in resectable pancreatic cancer (UNITEPANC) - UNITEPANC
Primary sponsor Universitaetsklinikum Ulm AöR
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No
Countries Germany
Conditions Patients with functionally resectable pancreatic ductal adenocarcinoma (PDAC) according to NCCN criteria and Ca19-9 <500 U/ml (without relevant cholestasis) MedDRA version: 21.0Level: PTClassification code: 10049073Term: Carbohydrate…
Interventions Product Name: , Product Code:SCP131876, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product Code:SCP129816, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product…
Registration date Sep 5, 2025
Target size 92
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations